PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF CYSTITIS OF VARIOUS ETIOLOGIES
A pharmaceutical sterile composition consisting of hyaluronic acid sodium salt and Hyaffl lp50 and related use in the intravesical treatment of interstitial cystitis or Bladder Pain Syndrome (IC/BPS), of acute cystitis following bacterial infection, trauma or urolithiasis, of cystitis caused by radi...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | ZANELLATO, Anna Maria PIZZOCARO, Carlo PAVAN, Mauro |
| description | A pharmaceutical sterile composition consisting of hyaluronic acid sodium salt and Hyaffl lp50 and related use in the intravesical treatment of interstitial cystitis or Bladder Pain Syndrome (IC/BPS), of acute cystitis following bacterial infection, trauma or urolithiasis, of cystitis caused by radiation, chemotherapy, and hemorrhagic cystitis, as well as in the treatment of the bladder of patients undergoing endoscopic resection of benign or malignant bladder tumour at risk of relapse, are described.
L'invention concerne une composition pharmaceutique stérile constituée de sel de sodium d'acide hyaluronique et d'Hyaffl lp50 et une utilisation associée dans le traitement intravésical de la cystite interstitielle ou du syndrome de douleur de la vessie (IC/BPS), de la cystite aiguë suite à une infection bactérienne, un traumatisme ou une urolithiase, de la cystite provoquée par rayonnement, chimiothérapie et de la cystite hémorragique, ainsi que dans le traitement de la vessie de patients subissant une résection endoscopique de tumeur de la vessie bénigne ou maligne à risque de rechute. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2021079303A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2021079303A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2021079303A13</originalsourceid><addsrcrecordid>eNqNi7EKwjAUALM4iPoPD5yFtBnEMYQXE2j6SvJScSpF4iRaqP-PFfwAp7vhbi1y53QM2mBmb3QDhkJHybOnFixFyAnBt8AOgSNqDtgykAVzTbxU6eu9jp5yAlyuhs4e01as7uNjLrsfN2JvkY07lOk1lHkab-VZ3sOFallX8nhSUulK_Vd9AEjUMZw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF CYSTITIS OF VARIOUS ETIOLOGIES</title><source>esp@cenet</source><creator>ZANELLATO, Anna Maria ; PIZZOCARO, Carlo ; PAVAN, Mauro</creator><creatorcontrib>ZANELLATO, Anna Maria ; PIZZOCARO, Carlo ; PAVAN, Mauro</creatorcontrib><description>A pharmaceutical sterile composition consisting of hyaluronic acid sodium salt and Hyaffl lp50 and related use in the intravesical treatment of interstitial cystitis or Bladder Pain Syndrome (IC/BPS), of acute cystitis following bacterial infection, trauma or urolithiasis, of cystitis caused by radiation, chemotherapy, and hemorrhagic cystitis, as well as in the treatment of the bladder of patients undergoing endoscopic resection of benign or malignant bladder tumour at risk of relapse, are described.
L'invention concerne une composition pharmaceutique stérile constituée de sel de sodium d'acide hyaluronique et d'Hyaffl lp50 et une utilisation associée dans le traitement intravésical de la cystite interstitielle ou du syndrome de douleur de la vessie (IC/BPS), de la cystite aiguë suite à une infection bactérienne, un traumatisme ou une urolithiase, de la cystite provoquée par rayonnement, chimiothérapie et de la cystite hémorragique, ainsi que dans le traitement de la vessie de patients subissant une résection endoscopique de tumeur de la vessie bénigne ou maligne à risque de rechute.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210429&DB=EPODOC&CC=WO&NR=2021079303A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,778,883,25551,76302</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210429&DB=EPODOC&CC=WO&NR=2021079303A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ZANELLATO, Anna Maria</creatorcontrib><creatorcontrib>PIZZOCARO, Carlo</creatorcontrib><creatorcontrib>PAVAN, Mauro</creatorcontrib><title>PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF CYSTITIS OF VARIOUS ETIOLOGIES</title><description>A pharmaceutical sterile composition consisting of hyaluronic acid sodium salt and Hyaffl lp50 and related use in the intravesical treatment of interstitial cystitis or Bladder Pain Syndrome (IC/BPS), of acute cystitis following bacterial infection, trauma or urolithiasis, of cystitis caused by radiation, chemotherapy, and hemorrhagic cystitis, as well as in the treatment of the bladder of patients undergoing endoscopic resection of benign or malignant bladder tumour at risk of relapse, are described.
L'invention concerne une composition pharmaceutique stérile constituée de sel de sodium d'acide hyaluronique et d'Hyaffl lp50 et une utilisation associée dans le traitement intravésical de la cystite interstitielle ou du syndrome de douleur de la vessie (IC/BPS), de la cystite aiguë suite à une infection bactérienne, un traumatisme ou une urolithiase, de la cystite provoquée par rayonnement, chimiothérapie et de la cystite hémorragique, ainsi que dans le traitement de la vessie de patients subissant une résection endoscopique de tumeur de la vessie bénigne ou maligne à risque de rechute.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNi7EKwjAUALM4iPoPD5yFtBnEMYQXE2j6SvJScSpF4iRaqP-PFfwAp7vhbi1y53QM2mBmb3QDhkJHybOnFixFyAnBt8AOgSNqDtgykAVzTbxU6eu9jp5yAlyuhs4e01as7uNjLrsfN2JvkY07lOk1lHkab-VZ3sOFallX8nhSUulK_Vd9AEjUMZw</recordid><startdate>20210429</startdate><enddate>20210429</enddate><creator>ZANELLATO, Anna Maria</creator><creator>PIZZOCARO, Carlo</creator><creator>PAVAN, Mauro</creator><scope>EVB</scope></search><sort><creationdate>20210429</creationdate><title>PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF CYSTITIS OF VARIOUS ETIOLOGIES</title><author>ZANELLATO, Anna Maria ; PIZZOCARO, Carlo ; PAVAN, Mauro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2021079303A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2021</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>ZANELLATO, Anna Maria</creatorcontrib><creatorcontrib>PIZZOCARO, Carlo</creatorcontrib><creatorcontrib>PAVAN, Mauro</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ZANELLATO, Anna Maria</au><au>PIZZOCARO, Carlo</au><au>PAVAN, Mauro</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF CYSTITIS OF VARIOUS ETIOLOGIES</title><date>2021-04-29</date><risdate>2021</risdate><abstract>A pharmaceutical sterile composition consisting of hyaluronic acid sodium salt and Hyaffl lp50 and related use in the intravesical treatment of interstitial cystitis or Bladder Pain Syndrome (IC/BPS), of acute cystitis following bacterial infection, trauma or urolithiasis, of cystitis caused by radiation, chemotherapy, and hemorrhagic cystitis, as well as in the treatment of the bladder of patients undergoing endoscopic resection of benign or malignant bladder tumour at risk of relapse, are described.
L'invention concerne une composition pharmaceutique stérile constituée de sel de sodium d'acide hyaluronique et d'Hyaffl lp50 et une utilisation associée dans le traitement intravésical de la cystite interstitielle ou du syndrome de douleur de la vessie (IC/BPS), de la cystite aiguë suite à une infection bactérienne, un traumatisme ou une urolithiase, de la cystite provoquée par rayonnement, chimiothérapie et de la cystite hémorragique, ainsi que dans le traitement de la vessie de patients subissant une résection endoscopique de tumeur de la vessie bénigne ou maligne à risque de rechute.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2021079303A1 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF CYSTITIS OF VARIOUS ETIOLOGIES |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T16%3A09%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ZANELLATO,%20Anna%20Maria&rft.date=2021-04-29&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2021079303A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |